During the last session, Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)’s traded shares were 1.6 million, with the beta value of the company hitting 0.25. At the end of the trading day, the stock’s price was $0.63, reflecting an intraday gain of 6.60% or $0.04. The 52-week high for the IRWD share is $7.11, that puts it down -1028.57 from that peak though still a striking 15.87% gain since the share price plummeted to a 52-week low of $0.53. The company’s market capitalization is $102.19M, and the average intraday trading volume over the past 10 days was 3.43 million shares, and the average trade volume was 3.35 million shares over the past three months.
Ironwood Pharmaceuticals Inc (IRWD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. IRWD has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) trade information
Ironwood Pharmaceuticals Inc (IRWD) registered a 6.60% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.60% in intraday trading to $0.63, hitting a weekly high. The stock’s 5-day price performance is 7.22%, and it has moved by -32.83% in 30 days. Based on these gigs, the overall price performance for the year is -89.39%. The short interest in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) is 8.47 million shares and it means that shorts have 2.63 day(s) to cover.
The consensus price target of analysts on Wall Street is $4, which implies an increase of 84.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1 and $7 respectively. As a result, IRWD is trading at a discount of -1011.11% off the target high and -58.73% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -47.49%. While earnings are projected to return 1644.75% in 2025, the next five years will return 141.01% per annum.
IRWD Dividends
Ironwood Pharmaceuticals Inc is due to release its next quarterly earnings on 2025-May-06. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)’s Major holders
Ironwood Pharmaceuticals Inc insiders own 2.53% of total outstanding shares while institutional holders control 97.46%, with the float percentage being 99.99%. BLACKROCK INC. is the largest shareholder of the company, while 284.0 institutions own stock in it. As of 2024-06-30, the company held over 22.88 million shares (or 14.3868% of all shares), a total value of $149.16 million in shares.
The next largest institutional holding, with 21.56 million shares, is of VANGUARD GROUP INC’s that is approximately 13.5607% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $140.59 million.
Also, the Mutual Funds coming in first place with the largest holdings of Ironwood Pharmaceuticals Inc (IRWD) shares are Pacer Funds Trust-Pacer US Small Cap Cash Cows ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. Data provided on Jan 31, 2025 indicates that Pacer Funds Trust-Pacer US Small Cap Cash Cows ETF owns about 11.05 shares. This amounts to just over 6.83 percent of the company’s overall shares, with a $6.97 million market value. The same data shows that the other fund manager holds slightly less at 4.19, or about 2.59% of the stock, which is worth about $2.65 million.
